Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
Cigna Group (NYSE: CI) closed the day trading at $302.11 up 1.27% from the previous closing price of $298.32. In other words, the price has increased by $1.27 from its previous closing price. On the day, 1.48 million shares were traded. CI stock price reached its highest trading level at $302.59 during the session, while it also had its lowest trading level at $298.0.
Ratios:
For a better understanding of CI, let’s look at its different ratios. In the meantime, Its Debt-to-Equity ratio is 0.77 whereas as Long-Term Debt/Eq ratio is at 0.66.
On June 26, 2024, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $400.
On May 30, 2024, Robert W. Baird started tracking the stock assigning a Outperform rating and target price of $388.Robert W. Baird initiated its Outperform rating on May 30, 2024, with a $388 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Aug 15 ’25 when Jones Nicole S sold 28,526 shares for $300.00 per share. The transaction valued at 8,557,800 led to the insider holds 25,648 shares of the business.
Jones Nicole S bought 28,526 shares of CI for $8,557,800 on Aug 15 ’25. On Aug 12 ’25, another insider, Eder Noelle K, who serves as the Former Officer of the company, bought 35,711 shares for $275.06 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CI now has a Market Capitalization of 80641613824 and an Enterprise Value of 105471983616. As of this moment, Cigna’s Price-to-Earnings (P/E) ratio for their current fiscal year is 16.50, and their Forward P/E ratio for the next fiscal year is 9.15. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.53. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.31 while its Price-to-Book (P/B) ratio in mrq is 2.00. Its current Enterprise Value per Revenue stands at 0.403 whereas that against EBITDA is 9.245.
Stock Price History:
The Beta on a monthly basis for CI is 0.49, which has changed by -0.1176694 over the last 52 weeks, in comparison to a change of 0.14064062 over the same period for the S&P500. Over the past 52 weeks, CI has reached a high of $370.83, while it has fallen to a 52-week low of $256.89. The 50-Day Moving Average of the stock is 0.20%, while the 200-Day Moving Average is calculated to be -2.09%.
Shares Statistics:
Over the past 3-months, CI traded about 1.88M shares per day on average, while over the past 10 days, CI traded about 1860880 shares per day. A total of 266.60M shares are outstanding, with a floating share count of 262.90M. Insiders hold about 1.51% of the company’s shares, while institutions hold 89.89% stake in the company. Shares short for CI as of 1753920000 were 2453026 with a Short Ratio of 1.30, compared to 1751241600 on 2923086. Therefore, it implies a Short% of Shares Outstanding of 2453026 and a Short% of Float of 1.2200001.
Dividends & Splits
CI’s forward annual dividend rate is 5.82, up from 5.82 a year ago. Against a Trailing Annual Dividend Yield of 0.019509252The stock’s 5-year Average Dividend Yield is 1.34. The current Payout Ratio is 46.19% for CI, which recently paid a dividend on 2025-06-03 with an ex-dividend date of 2025-09-04. Stock splits for the company last occurred on 2007-06-05 when the company split stock in a 3:1 ratio.
Earnings Estimates
At present, 22.0 analysts are actively evaluating the performance of Cigna Group (CI) in the stock market.The consensus estimate for the next quarter is $8.05, with high estimates of $8.47 and low estimates of $7.48.
Analysts are recommending an EPS of between $29.86 and $29.23 for the fiscal current year, implying an average EPS of $29.66. EPS for the following year is $33.02, with 24.0 analysts recommending between $34.0 and $32.07.
Revenue Estimates
11 analysts predict $67.03B in revenue for the current quarter. It ranges from a high estimate of $68.59B to a low estimate of $64.85B. As of the current estimate, Cigna Group’s year-ago sales were $63.69BFor the next quarter, 11 analysts are estimating revenue of $68.05B. There is a high estimate of $70.44B for the next quarter, whereas the lowest estimate is $65.6B.
A total of 18 analysts have provided revenue estimates for CI’s current fiscal year. The highest revenue estimate was $271.25B, while the lowest revenue estimate was $253.07B, resulting in an average revenue estimate of $263.3B. In the same quarter a year ago, actual revenue was $247.1BBased on 17 analysts’ estimates, the company’s revenue will be $274.3B in the next fiscal year. The high estimate is $289.14B and the low estimate is $261.94B.
